Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dosing regimens associated with extended release paliperidone injectable formulations

Dosing regimens associated with extended release paliperidone injectable formulations

US Patent 11324751 · Granted May 10, 2022

Estimated economic value: $396,684,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dosing regimens associated with extended release paliperidone injectable formula2025
Compositions and methods for the treatment of depression2025
Dosing regimens associated with extended release paliperidone injectable formula2025
Dosing regimens associated with extended release paliperidone injectable formula2025
Dosing regimens associated with extended release paliperidone injectable formula2025
Compositions comprising aticaprant2025
Forms of aticaprant2024
Compositions and methods for the treatment of depression2024
Compositions and methods for the treatment of depression2024
Forms of aticaprant2024
Compositions and methods for the treatment of depression2024
Methods of identifying schizophrenia patients at risk for relapse2023